NCADD-SD News & Blog

News and Information from NCADD-SD

Connect People With Support Services to Fight Opioid Epidemic: Surgeon General

Connect People With Support Services to Fight Opioid Epidemic: Surgeon General

Connecting people with support services such as food and housing is a key step in curbing the opioid epidemic, Surgeon General Jerome Adams said recently.

“We’ve got to be more innovative in terms of helping folks understand that providing all these services will increase their chances of success and ultimately lower cost,” Adams said at an event sponsored by Faces and Voices of Recovery and Indivior. “That’s what I want Congress to know, that’s what I want policymakers to know — we’re not throwing good money after bad; we’re actually getting a return on investment by wrapping people with the support services they need to be successful in recovery.”

Adams said his brother self-medicated to cope with untreated mental health issues, The Hill reports.

“He ended up committing criminal activity to support his habit and is now in state prison a few miles away from here in Maryland because of his addiction, still not getting treatment,” Adams said, a story he called “far too common.”


Original linkOriginal author: Ezra
17 Hits

OxyContin Maker Announces It Will No Longer Market Drug to Doctors

OxyContin Maker Announces It Will No Longer Market Drug to Doctors

Purdue Pharma, the maker of OxyContin, said it will no longer market the drug to doctors.

The announcement comes in response to lawsuits that blame the company for helping to trigger the opioid crisis, CBS News reports.

The company said it has eliminated more than half its sales staff, and will no longer send sales representatives to doctors’ offices to talk about opioid medications.

OxyContin is the world’s top-selling opioid painkiller. Purdue, along with pharmaceutical distributors and other companies that make opioids, are defending themselves against hundreds of state and local lawsuits that aim to hold the drug industry accountable for the opioid epidemic, the article notes. The lawsuits are seeking money and changes to how the industry operates.

Original linkOriginal author: Ezra
20 Hits

The Great Opioid Lie


More than 500,000 people have died from prescription drug overdoses just since the year 2000 – while the industry making these opioids earned an estimated $200 billion from the sales of these pills. Beyond this staggering human toll, prescription opioid misuse costs our economy nearly $80 billion per year. Today, more than three-quarters of those suffering from heroin addiction used prescription opioids prior to heroin.

How we got to this point is complicated. But one thing is clear: the crisis began with big pharma’s great Opioid Lie.

Learn More

69 Hits

Treating Depression May Help Patients Stop Long-Term Prescription Opioid Use

Treating Depression May Help Patients Stop Long-Term Prescription Opioid Use

Patients with long-term opioid prescriptions and depression who take antidepressants are more likely to stop using opioids, a new study concludes.

“Depression can worsen pain and is common in patients who remain long-term prescription opioid users,” lead researcher Jeffrey Scherrer, PhD, of Saint Louis University said in a news release. “Our study should encourage clinicians to determine if their non-cancer pain patients are suffering from depression and aggressively treat patients’ depression to reduce opioid use.”

He added, “Effective depression treatment may break the mutually reinforcing opioid-depression relationship and increase the likelihood of successful opioid cessation.”

The findings will be published in British Journal of Psychiatry.

Original linkOriginal author: Ezra
49 Hits

Long-Term Marijuana Use Is Associated With Health Problems Later in Life

Long-Term Marijuana Use Is Associated With Health Problems Later in Life

Attitudes and policies regarding recreational marijuana use are becoming increasingly permissive.

To effectively address the implications of these developments, researchers and policy makers need to understand how much and how long people use marijuana during the lifespan, and the degree to which different use patterns are associated with long-term issues such as health status.

This study found that:

Marijuana users exhibited six different patterns of marijuana use from ages 18 to 50.Longer-term marijuana use (extending from age 18 into the late 20s or beyond) was associated with increased risk of self-reported health problems at age 50.

To this end, Yvonne Terry-McElrath of the University of Michigan and her colleagues applied the statistical technique of latent class analysis to identify distinct patterns of marijuana use from age 18 to 50 among nearly 10,000 participants in the Monitoring the Future (MTF) study. The participants had reported their past-year marijuana use when they were high school seniors in 1976–1983, at 2-year intervals through age 30, and then at 5-year intervals until they reached age 50.

The researchers emphasize that their results do not necessarily indicate that marijuana caused the users’ health problems. “Our findings do not confirm causality,” Ms. Terry-McElrath says. “We can say that, among these participants, those who reported longer use patterns also reported higher levels of negative health outcomes, even after we controlled for numerous demographic and behavioral characteristics.” She notes that other research has also linked cannabis use to poor health.

48 Hits

“Deaths of Despair” Caused by Opioids, Alcohol and Suicides: Report

“Deaths of Despair” Caused by Opioids, Alcohol and Suicides: Report

The incresing rate of deaths due to opioids, alcohol and suicides are part of a public health crisis described as “deaths of despair” in a new report published recently.

Life expectancy in the United States has decreased for the second year in a row because of these factors, researchers wrote in BMJ.

The drop was particularly steep among middle-age white Americans and people living in rural areas, USA Today reports.

“Why white Americans are dying at higher rates from drugs, alcohol, and suicides is unclear, complex, and not explained by opioids alone,” the researchers wrote. They note that possibilities include the collapse of industries and the local economies they supported, the erosion of social cohesion and greater social isolation, economic hardship, and distress among white workers over losing the security their parents once enjoyed.

Original linkOriginal author: Ezra
57 Hits

State and Local Law Enforcement Officials Protest Cut to Drug Prevention Program

State and Local Law Enforcement Officials Protest Cut to Drug Prevention Program

State and local law enforcement officials came to Capitol Hill last week to protest a Trump Administration proposal to move oversight of a drug prevention program from the Office of National Drug Control Policy (ONDCP) to the Justice Department.

The High Intensity Drug Trafficking Areas Program sends millions of federal dollars to 28 task forces across the country.

The task forces, composed of state, local and federal law enforcement officers, use the funds to combat drug trafficking in their communities, The New York Times reports.

Under a draft budget plan from the Office of Management and Budget, the $275 million program would be run by federal law enforcement officers.

“In the middle of this huge epidemic, is now the time to start rearranging the deck chairs?” said Chauncey Parker, the director of the program task force in New York City. “ONDCP are the experts and the professionals on this issue, and they’re the best ones from a holistic standpoint to be able to take a look at all of this.”

Original linkOriginal author: Ezra
54 Hits

FDA Calls Kratom an Opioid

FDA Calls Kratom an Opioid

The Food and Drug Administration (FDA) is warning that the supplement known as “kratom” is an opioid and has been linked with 44 deaths, The Washington Post reports.

Kratom, an unregulated botanical substance, is used by some people to relieve pain, anxiety and depression, as well as symptoms of opioid withdrawal.

The FDA recently conducted a scientific analysis that provided even stronger evidence of kratom’s opioid properties, the agency said in a statement. “We have been especially concerned about the use of kratom to treat opioid withdrawal symptoms, as there is no reliable evidence to support the use of kratom as a treatment for opioid use disorder and significant safety issues exist,” said FDA Commissioner Scott Gottlieb.

The analysis has “contributed to the FDA’s concerns about kratom’s potential for abuse, addiction, and serious health consequences; including death.”

Original linkOriginal author: Ezra
23 Hits

Naloxone Administration May Lead to Complications

Naloxone Administration May Lead to Complications

There seem to be a growing number of cases of high amounts of fluid in the lungs – known as noncardiogenic pulmonary edema – following administration of the opioid overdose antidote naloxone, experts said at a recent meeting of the New York Society of Addiction Medicine annual meeting.

“The cause of naloxone-associated pulmonary edema is unclear. It may be that it is part of the natural history of opioid overdose, and we are just seeing it more often because we have the ability to save patients using an antidote. It could also be because when we wake people with naloxone, they try to take a deep breath against a closed airway, causing barotraumas – injuries caused by increased air or water pressure,” says Nicholas Nacca, MD, Assistant Professor of Emergency Medicine and Medical Toxicologist at the University of Rochester Medical Center.

There is no hard data to support that this phenomenon has increased in frequency, but it certainly seems to be the case, he said. “The dose and route of administration have changed recently. Naloxone is now available in 4-milligram intranasal doses, which is higher than what we have used in the past,” said Dr. Nacca. “Previously, naloxone was available in 2-milligram doses.” In the controlled setting of an emergency room, toxicologists recommend giving the lowest dose of naloxone possible to reverse the respiratory arrest. This is different than in the field, where first responders, police and lay persons are using preloaded intranasal drug delivery devices.

“Lives are being saved by these doses of naloxone, and at this time, complications may be a necessary evil,” he said.

Another common issue with naloxone administration is that first responders may be used to administering naloxone via intramuscular or intravenous injection.

48 Hits

New Treatment Guidance Issued For Pregnant Mothers with Opioid Use Disorder

New Treatment Guidance Issued For Pregnant Mothers with Opioid Use Disorder

The Substance Abuse and Mental Health Services Administration (SAMHSA) released new Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants.

SAMHSA’s Clinical Guidance comes at a time of great need for effective opioid use disorder (OUD) treatment.

In 2016, over 20,000 pregnant women reported using heroin or misusing pain relievers in the past month. Newborn babies of mothers who used opioids while pregnant are at risk of neonatal abstinence syndrome--a group of physical and neurobehavioral signs of withdrawal.

“SAMHSA is filling an urgent need for reliable, useful, and accurate information for healthcare professionals working to treat opioid dependent mothers and their children,” said Dr. Elinore F. McCance-Katz, SAMHSA’s Assistant Secretary for Mental Health and Substance Use. “Ultimately, the steps explained in this guidance will help the mother and her infant safely receive treatment for opioid use disorder and neonatal abstinence syndrome.”

The Clinical Guidance offers standard approaches to a range of real-world scenarios faced by healthcare professionals working with mothers and infants. For each scenario, the guidance offers clinical action steps and supporting evidence. The action steps reflect the best available treatment, including medication-assisted treatment for the mother and infant and appropriate types of social supports and follow-up services.

37 Hits

Getting the Right Help for Opioid Dependence or Withdrawal

Getting the Right Help for Opioid Dependence or Withdrawal

Do you know someone seeking treatment for opioid dependence or withdrawal?

If so, it’s important to know this: products that promise miracle cures or fast results cancost precious time and money, lead to relapse, and even be dangerous.

Dietary supplements — such as herbal blends, vitamins, and minerals — have not been scientifically proven to ease withdrawal or to treat opioid dependence.Products like Kratom, which some claim can help, are actually not proven treatments, and can be addictive and dangerous to your health.Opioid dependence and withdrawal are serious health issues. You can address them with time, hard work, and help. But there are no quick fixes.

If you or someone you know is considering treatment for opioid dependence or withdrawal, start here:

Call SAMHSA’s National Helpline: 1-800-662-HELP (4357)Get live help from this free, confidential, 24/7, 365-day-a-year treatment referral and information service (in English and Spanish) for people and families facing substance use disorders.Visit SAMHSA’s confidential treatment locator: https://findtreatment.samhsa.govFind a reputable treatment facility near you in a quick, confidential online search.

Before taking any dietary supplement — for any medical reason — ask a health provider these questions:

Is there scientific proof it actually works?How reliable is this brand?How will it interact with other supplements or drugs I take?What are the side effects?If it’s safe to take, what’s the right amount?

Learn more by clicking here.

33 Hits

Antipsychotic Drugs May Finally Be Poised For a Long-Overdue Makeover

Antipsychotic Drugs May Finally Be Poised For a Long-Overdue Makeover

Antipsychotic drugs – which transformed mental health care following their chance discovery in the mid-20th Century – may finally be poised for a long-overdue makeover incorporating structure-based design.

Scientists funded by the National Institutes of Health have achieved a landmark of psychiatric neuropharmacology: deciphering the molecular structure of a widely prescribed antipsychotic docked in its key receptor. They are hopeful that this discovery may hold secrets to designing better treatments for schizophrenia, bipolar disorder, and other mental illnesses.

“For the first time, we can understand precisely how atypical antipsychotic drugs bind to their primary molecular target in the human brain,” explained Dr. Laurie Nadler, chief of the neuropharmacology program at the National Institute of Mental Health (NIMH), which co-funded the study along with the National Institute of General Medical Sciences and the National Cancer Institute. “This discovery opens the way for the rational design of a new generation of antipsychotic drugs, hopefully with more desirable effects and fewer side effects.”

Researchers Bryan Roth, M.D., Ph.D. (link is external), of the University of North Carolina (UNC) Chapel Hill, Brian Shoichet, Ph.D., (link is external) of the University of California San Francisco, and colleagues, report on their discovery of the crystal structure of the antipsychotic risperidone docked in the D2 dopamine receptor in the journal Nature.

Before becoming a laboratory scientist, psychiatrist Roth experienced first-hand the limitations of existing antipsychotics while treating patients with schizophrenia. The medications excel at quelling hallucinations and delusions, yet largely fail to address schizophrenia’s debilitating cognitive and social impairments, while increasing risk for movement disorders, weight gain, and other metabolic and cardiovascular side effects.

61 Hits

Children of Alcoholics Week is Held February 11-17 2018

Children of Alcoholics Week is Held February 11-17 2018

Children of Alcoholics (COA) Week is a campaign led by Nacoa (The National Association for Children of Alcoholics) to raise awareness of children affected by parental alcohol problems.

Imagine coming home from school and dreading what you might find. Imagine having no friends because you’re too embarrassed to bring them home in case mom or dad are drunk, or worse. Imagine living in a home full of fear and having no one to turn to because everyone denies there’s a problem.

Together we can increase awareness of this hidden problem and the support available. Find out how you can help children of all ages know they are not alone.

This year, under the slogan “All you need is Love”, the Children of Alcoholics week activities of Active – Sobriety, Friendship and Peace reflect on love and safety, as not just feelings that children experience, but also part of children’s rights.

Children of Alcoholics Week is celebrated internationally each year during the week in which Valentine’s Day falls. There are organisations holding COA Week activities in USA, Germany, Poland, Sweden and Slovenia.

62 Hits

Fentanyl-Related Substances Temporarily Placed as Schedule I Drugs

Fentanyl-Related Substances Temporarily Placed as Schedule I Drugs

It is well known that deaths associated with the abuse of substances structurally related to fentanyl in the United States are on the rise and have already reached alarming levels.

While a number of factors appear to be contributing to this public health crisis, chief among the causes is the sharp increase in recent years in the availability of illicitly produced, potent substances structurally related to fentanyl. Fentanyl is approximately 100 times more potent than morphine, and the substances structurally related to fentanyl that DEA is temporarily controlling also tend to be potent substances. Typically, these substances are manufactured outside the United States by clandestine manufacturers and then smuggled into the United States.

As a result, the Administrator of the Drug Enforcement Administration has issued a temporary scheduling order to schedule fentanyl-related substances that are not currently listed in any schedule of the Controlled Substances Act (CSA) and their isomers, esters, ethers, salts and salts of isomers, esters, and ethers in schedule I.

This action is based on a finding by the Administrator that the placement of these synthetic opioids in schedule I is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle fentanyl-related substances.

This temporary scheduling order is effective February 6, 2018, until February 6, 2020.

60 Hits

Study of First-Graders Shows Fetal Alcohol Spectrum Disorders Prevalent In U.S. Communities

Study of First-Graders Shows Fetal Alcohol Spectrum Disorders Prevalent In U.S. Communities

NIH-funded research examined over 6,000 children to determine prevalence of FASD ranged from 1.1 to 5 percent.

A study of more than 6,000 first-graders across four U.S. communities has found that a significant number of the children have fetal alcohol spectrum disorders (FASD), with conservative rates ranging from 1 to 5 percent in community samples. The new findings represent more accurate prevalence estimates of FASD among general U.S. communities than prior research. Previous FASD estimates were based on smaller study populations and did not reflect the overall U.S. population. The study was funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health.

FASD is an umbrella term for a range of health effects caused by prenatal alcohol exposure. Individuals with FASD may experience growth deficiencies, facial abnormalities, and organ damage, including to the brain. The effects of prenatal alcohol exposure on the brain can result in a range of neurobiological deficits that contribute to physical, cognitive, behavioral, and social challenges throughout life.

“Prenatal alcohol exposure is a leading preventable cause of developmental disabilities worldwide,” said NIAAA Director George F. Koob, Ph.D. “Estimating the prevalence of FASD in the United States has been complex due to the challenges in identifying prenatally exposed children. The findings of this study confirm that FASD is a significant public health problem, and strategies to expand screening, diagnosis, prevention, and treatment are needed to address it.”

The study was conducted by the Collaboration on Fetal Alcohol Spectrum Disorders Prevalence (CoFASP) consortium, which studies the prevalence of FASD among U.S. school children. Before the study began, consortium members established standardized classification criteria for FASD based on facial features, growth, and neurodevelopmental performance. Co-led by Philip May, Ph.D., of the University of North Carolina Nutrition Research Institute, Kannapolis, and Christina Chambers, Ph.D., of the University of California San Diego School of Medicine, the findings are reported online in the Journal of the American Medical Association.

63 Hits

Philadelphia Encourages Development of Sites for Supervised Injection Drug Use

Philadelphia Encourages Development of Sites for Supervised Injection Drug Use

Philadelphia officials are encouraging organizations to open facilities where staff members provide clean needles and guard against overdoses.

Advocates for these facilities say they would save lives. Opponents say they sanction an illegal activity, and make it easier for people to use drugs, The Wall Street Journal reports.

The Philadelphia facilities would offer a wide range of services, including referrals to treatment and social services, wound care, medically supervised drug consumption, and access to sterile injection equipment and the opioid overdose antidote naloxone, according to a news release.

City officials said a scientific review of studies of supervised injection facilities showed they reduce deaths from drug overdose; prevent HIV, hepatitis C and other infections; and help people who use drugs get into treatment.

The review estimated that one site in Philadelphia could prevent up to 76 deaths from drug overdose each year.

Original linkOriginal author: Ezra
39 Hits

What Today’s Parents Should Know About the Gateway Drug Theory

What Today’s Parents Should Know About the Gateway Drug Theory

While scanning the latest news, it’s easy to feel as if we’ve traveled back in time to the 1980s. “Just say no?” “The war on drugs?”

After nearly three decades, there’s still little evidence to suggest these outdated addiction prevention and treatment strategies work, and some evidence even shows that they are counterproductive. Yet, they continue to influence how we both talk about and treat addiction. And just last month, dialogue about the “gateway drug theory” resurfaced in the New York Times, raising the question: is this highly publicized hypothesis, which also originated in the final quarter of the 20th century, grounded in fact or fiction? We answer this question – and more – below.

WHAT IS THE GATEWAY DRUG THEORY?First popularized in the 1980s, the gateway drug theory purports that adolescent use of tobacco, alcohol or marijuana increases an individual’s risk of using and/or developing addiction to other licit and illicit substances that may be perceived as more harmful, such as opioids, cocaine and methamphetamines.

ARE TOBACCO, ALCOHOL AND MARIJUANA GATEWAY DRUGS?In a sense, yes, but the important thing to note is that every drug is a gateway drug if used during adolescence or young adulthood while brain development is still underway.Whether it’s nicotine, alcohol, marijuana or opioids, it is the age of the person initiating use – not the specific substance itself – that increases the risk of using other addictive substances and developing addiction.

WHY ARE YOUNG PEOPLE WHO SMOKE, DRINK OR USE DRUGS MORE SUSCEPTIBLE TO DEVELOPING ADDICTION?During adolescence, the human brain goes through numerous developmental changes in structure and function. While the areas of the brain associated with memory, learning, judgment, decision-making, risk-taking, reward, emotion and stress are maturing, they are uniquely vulnerable to the damage that addictive substances such as nicotine, alcohol and other drugs inflict on these critical brain functions. That damage to the brain not only makes the individual more susceptible to addiction, but it also further impairs the skills needed to make good decisions and sound judgements, heightening the risk of future substance use and addiction.

24 Hits

Opioid Public Health Emergency Renewed for Another 90 Days

Opioid Public Health Emergency Renewed for Another 90 Days

The Trump Administration renewed the order declaring the opioid crisis a public health emergency on January 22, a day before the 90-day mandate was set to expire, ABC News reports.

The Department of Health and Human Services has not said whether the public health emergency will be renewed every 90 days, the article notes.

In October, President Trump declared the opioid crisis a public health emergency. The order waives regulations and gives states more flexibility in how they use federal funds to combat the crisis.

Under a public health emergency, states could temporarily shift federal grant funds from a wide range of public health issues—such as HIV, diabetes and maternal care—to fund opioid treatment programs. A public health emergency is not as sweeping as a national emergency, which would give the president even more power to waive privacy laws and Medicaid regulations, the article notes.

Original linkOriginal author: Ezra
35 Hits

Fear Factor: Do Scare Tactics Keep Teens from Using Drugs

Fear Factor: Do Scare Tactics Keep Teens from Using Drugs

Thinking back to your middle school or high school health classes, you may recall photographs of lungs blackened by cigarette tar or videos of teenagers dropping out of school, fighting with friends and family, or even dying because of their errant drug and alcohol use.

Exposing children and teenagers to the most damaging consequences of these behaviors has long been a mainstay in America’s addiction prevention strategy – but that poses the question: do scare tactics work?

There is evidence to suggest that scaring people can help them adopt or avoid certain behaviors – this is especially true when the proposed negative outcome is paired with an “efficacy method” or something people can do to eradicate the fear.

It also tends to work better when it comes to:

One-time only or infrequent prevention behaviors, e.g., going to the dentist for a checkupBehaviors that detect a health problem, e.g., having a suspicious mole checked for cancer, getting a mammogram

And worse for:

31 Hits

FDA Asks Makers of Anti-Diarrhea Drug to Change Packaging to Curb Abuse

FDA Asks Makers of Anti-Diarrhea Drug to Change Packaging to Curb Abuse

The Food and Drug Administration (FDA) this week asked the makers of the over-the-counter anti-diarrhea drug loperamide (Imodium A-D) to change the way they package their products, in an effort to reduce abuse.

Some people take extremely high doses of loperamide in an attempt to manage opioid withdrawal symptoms or to achieve euphoric effects of opioid use, the FDA said in a statement.

Loperamide is safe when used at recommended doses, The Washington Post reports. But when it is taken at extremely high doses, the drug can cause dangerous, irregular heartbeats.

The FDA is asking manufacturers to redesign their packages so they contain only enough medication for short-term use. The agency is also asking for “unit dose packaging,” such as blister packs that require a person to unpeel each dose separately.

Original linkOriginal author: Ezra
25 Hits